These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 35502084)
1. Bilateral blindness in a young male of rhino-orbital-cerebral mucormycosis: A case report. Kaur R; Sehgal A; Khan B; Budhiraja G; Roychoudhury AK; Kaur M Indian J Ophthalmol; 2022 May; 70(5):1822-1824. PubMed ID: 35502084 [TBL] [Abstract][Full Text] [Related]
2. Case series of central retinal artery occlusion in COVID-19-associated rhino-orbital-cerebral mucormycosis. Kamath GM; Jeganathan S; Salim S; Antony RM; Kamath AR; Hiran H Indian J Ophthalmol; 2023 Jul; 71(7):2904-2906. PubMed ID: 37417144 [TBL] [Abstract][Full Text] [Related]
3. Central retinal artery occlusion as the presenting manifestation of invasive rhino-orbital-cerebral mucormycosis. Bawankar P; Lahane S; Pathak P; Gonde P; Singh A Taiwan J Ophthalmol; 2020; 10(1):62-65. PubMed ID: 32309127 [TBL] [Abstract][Full Text] [Related]
4. Exudative retinal detachment in COVID-19 - associated rhino-orbital mucormycosis - A rare clinical finding. Sarkar S; Gokhale T; Kaliaperumal S; Singh R; Begam RB; Deb AK Indian J Ophthalmol; 2021 Sep; 69(9):2535-2537. PubMed ID: 34427262 [TBL] [Abstract][Full Text] [Related]
5. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable. Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359 [TBL] [Abstract][Full Text] [Related]
6. A Case of Bilateral Central Retinal Artery Occlusion in a Post-COVID Rhino-Orbital-Cerebral Mucormycosis Patient. Patnaik A; Sharma B; Ahmad R; Kumar A; Chitrotpala R; Gupta M Cureus; 2021 Nov; 13(11):e20062. PubMed ID: 35003938 [TBL] [Abstract][Full Text] [Related]
7. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895 [TBL] [Abstract][Full Text] [Related]
8. Rhino-orbito-cerebral mucormycosis in an immunocompetent patient: case report and review of literature. Shatriah I; Mohd-Amin N; Tuan-Jaafar TN; Khanna RK; Yunus R; Madhavan M Middle East Afr J Ophthalmol; 2012; 19(2):258-61. PubMed ID: 22623872 [TBL] [Abstract][Full Text] [Related]
9. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis. Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140 [TBL] [Abstract][Full Text] [Related]
10. Central Retinal Artery Occlusion in Rhino-Orbital-Cerebral Mucormycosis: An Inflammatory-Prothrombotic State. Tandon M; Sheemar A; Bhatnagar K; Meena S; Shakrawal J Asia Pac J Ophthalmol (Phila); 2023 Jan-Feb 01; 12(1):16-20. PubMed ID: 36706330 [TBL] [Abstract][Full Text] [Related]
11. Rhino-orbital mucormycosis in a patient with no susceptibility following P.vivax malaria infection-a case report. Prasad S; Gaur A; Mehta A; Kaushal N BMC Ophthalmol; 2022 Oct; 22(1):389. PubMed ID: 36183076 [TBL] [Abstract][Full Text] [Related]
12. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India. Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004 [TBL] [Abstract][Full Text] [Related]
13. Comment on: Case series of central retinal artery occlusion in COVID-19-associated rhino-orbito-cerebral mucormycosis. Thomas PA Indian J Ophthalmol; 2024 Feb; 72(2):299-300. PubMed ID: 38273694 [No Abstract] [Full Text] [Related]
14. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus. Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273 [TBL] [Abstract][Full Text] [Related]
15. The potential for rapid antigen testing for mucormycosis in the context of COVID-19. Thornton CR Expert Rev Mol Diagn; 2024 Mar; 24(3):161-167. PubMed ID: 37405409 [TBL] [Abstract][Full Text] [Related]
16. Central retinal vein occlusion as primary ocular manifestation of rhino-orbital-cerebral mucormycosis: A case report. Sethi NK; Chadha C; Bajaj M; Moond H Indian J Ophthalmol; 2022 Dec; 70(12):4451-4453. PubMed ID: 36453365 [TBL] [Abstract][Full Text] [Related]
17. Clinical Profile of Central Nervous System Involvement in Patients with Rhino Orbital Cerebral Mucormycosis. Yadav S; Bs N; Ak S J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443423 [TBL] [Abstract][Full Text] [Related]
18. Comment on: Case series of central retinal artery occlusion in COVID-19-associated rhino-orbito-cerebral mucormycosis. Kamath GM; Jeganathan S; Salim S; Antony RM; Kamath AR; Hiran H Indian J Ophthalmol; 2024 May; 72(5):755-756. PubMed ID: 38648440 [No Abstract] [Full Text] [Related]
19. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India. Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435 [TBL] [Abstract][Full Text] [Related]
20. Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review. Dave TV; Nair AG; Joseph J; Freitag SK Orbit; 2022 Dec; 41(6):670-679. PubMed ID: 35856238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]